Rho Chi Post

An award-winning, electronic, student-operated newsletter publication by the St. John's University College of Pharmacy and Health Sciences Rho Chi Beta Delta chapter

Menu

Skip to content
  • Home
  • Issues
    • Current Issue
    • All Issues
  • Articles
    • Featured
    • In the News / Politics
    • Events
    • Clinical
    • Advice / Opinions
    • Puzzles
    • Recently in PubMed
  • For Authors
    • Author Guidelines
    • AMA Citation Generator
    • Sign Up for Article(s)
    • Suggest Article(s)
    • Submit Article(s)
    • Check Statuses
    • Cite Your Article
  • About Us
    • About the Rho Chi Post
    • The Editorial Team
  • Apply for a Position
  • Subscribe
  • Login

In the News / Politics

Plan B® Pill Now Available Without Prescription to Wom...
May 1, 2013 - Featured , In the News / Politics

By: Bansri Patel – As of May 1st 2013, Plan B®, the brand name emergency contraception pill will now be available to women aged fifteen and older. It will also be sold in the drug store aisles, as opposed to its current location behind the pharmacy counter. When levonorgestrel (Plan B®) first entered the market,…

Three-Person In Vitro Fertilization: Combating Mitochon...
April 1, 2013 - Featured , In the News / Politics

By: Bharat Kirthivasan – The UK government might soon become the platform for an explosive debate on the utility and ethics of three-person in vitro fertilization (three-person IVF). According to the Human Fertilization & Embryology Authority, there is no evidence to suggest that any form of IVF is unsafe for the mother or the fetus.…

Merck Settles Lawsuits Over Vytorin...
April 1, 2013 - In the News / Politics

By: Tasnima Nabi, Staff Editor – Merck & Co. will pay $688 million to settle two lawsuits filed in December 2008 over their patent-protected statin, Vytorin®.  The suits state that Merck and Schering-Plough delayed releasing the results of their ENHANCE study to avoid a decrease in revenue.1 Vytorin® is a combination drug of simvastatin and…

Increased Costs of Treatment due to the DSM-V: Implicat...
April 1, 2013 - Featured , In the News / Politics

By: James W. Schurr and David Gao, PharmD Candidates 2014 – A recent Op-ed in Newsday by Allen Frances, MD (of Duke University School of Medicine and chairman of the task force that produced the DSM-IV, the current guidelines for psychiatric disease diagnosis) criticizes the American Psychiatric Association for being “extravagantly indifferent to all matters…

U.S. v Caronia: Misdemeanor or Constitutional Right?...
March 1, 2013 - Featured , In the News / Politics

By: Tamara Yunusova, Staff Editor – On December 3, 2012, the U.S. Second Circuit Court of Appeals became the first court in the nation to authorize off-label drug promotion under the First Amendment.  The heavily-disputed ruling, which is headed for further appeal, will have far-reaching implications for pharmaceutical companies and drug regulation policy. In a…

Extending the Standing Order for Tdap...
February 1, 2013 - Featured , In the News / Politics

By:  Christina Tarantola, PharmD, PGY-1 Resident at Kings Pharmacy – The New York State Department of Health issued a health advisory on November 8, 2012 in response to Hurricane Sandy. The document outlined guidelines on recommended immunizations and disaster relief efforts for volunteers and the general public. Due to an increased risk of exposure to…

College of Pharmacy and Health Sciences Collaborates...
February 1, 2013 - In the News / Politics

By:  Tasnima Nabi, Associate Student Editor – St. John’s University College of Pharmacy and Health Sciences has collaborated with the Union Square Academy of Health Sciences (U. S. A.) to prepare high school students for the pharmacy profession.  This partnership is one of the many projects of the “Urban Pharmaceutical Care, Research and Education Institute,”…

A Look at Primary Medication NonAdherence and How it ca...
February 1, 2013 - Featured , In the News / Politics

By:  Erica Dimitropoulos, Assistant Student Editor – Although clinical trials can affirm the efficacy and advantages of all marketed medications, it is obvious that patients cannot benefit from a drug that they choose not to take. Therefore, promoting medication adherence is one of the easiest and most affordable ways to improve treatment outcomes. In order…

Varizig® for Chickenpox Symptoms...
January 1, 2013 - In the News / Politics

By: Steve Soman, Co-Editor-in-Chief – Varicella Zoster Immune Globulin (Varizig®) was approved by the FDA on December 21st of 2012. The Canadian pharmaceutical company Cangene Corporation, which is owned in-part by Apotex Inc., markets the new product.  The drug was approved by the Food and Drug Administration (FDA) to reduce “the severity of chicken pox…

The Opioid Debate: PROP and PROMPT Battle Away...
January 1, 2013 - Featured , In the News / Politics

By: Tamara Yunusova – On Wednesday, July 25th a petition signed by the reform group Physicians for Responsible Opioid Prescribing (PROP) called on the FDA to implement opioid label changes that would restrict Chronic Non-Cancer (CNCP) opioid treatment for patients with severe pain only.  It wasn’t too long before another petition signed by PROP’s adversary,…

New Healthcare Law Concerning Birth Control Causes Deba...
January 1, 2013 - Featured , In the News / Politics

By: Katie Cimmino, Pharm D. Candidate c/o 2015 –  With the start of the New Year the French government is enacting a new law concerning contraceptives. Now girls between the ages of 15 to 18 will be able to obtain free birth control.  Not only will they have access to it, but the French government…

FDA Approves Apixaban For Nonvalvular Atrial Fibrillati...
January 1, 2013 - Clinical , Featured , In the News / Politics

By: Alexandra Alleva, PharmD candidate c/o 2013 – As of December 28th, Bristol-Myers Squibb and Pfizer’s brand name oral anticoagulant, Eliquis® (apixaban), attained FDA approval.1  This occurred one month after its approval in  Europe and Canada, following longer than expected waits in the US due to further investigation requests by the FDA.2 The much-anticipated anticoagulant is…

White House Petition Seeks to Recognize Pharmacists as ...
January 1, 2013 - Featured , In the News / Politics

By: Mohamed Dungersi, Associate Student Editor – A recent We the People petition on the White House official website has reached the 25,000 signature threshold needed to trigger an official response.  The petition tilted “Recognize pharmacists as health care providers”, was initiated by the current editor in chief of the Rho Chi Post, Steve Soman.1 …

Tackling America’s Drug Shortage Crisis...
December 1, 2012 - Featured , In the News / Politics , Professional Advice / Opinions

By: John S Lim, PharmD Candidate c/o 2013 – America’s focus on healthcare, as well as its position as one of the wealthiest nations of the industrialized world, is incongruous with the consequences of drug shortages suffered by its population. Shortages in pharmaceutical supply compromise quality of life while increasing health care costs. The pharmaceutical…

Adverse Events from Ingestion of OTC Eye Drops and Nasa...
December 1, 2012 - Featured , In the News / Politics

By Tasnima Nabi, PharmD Candidate c/o 2016 – The FDA has issued warnings on accidental ingestion of over-the-counter eye drops and nasal sprays because they can cause serious harm in children at and under the age of five. Ingestion of as little as 0.6 ml of OTC nasal decongestants and redness-relief eye drops has been…

Giving a Second Chance: The Prescription Drug Abuse Epi...
December 1, 2012 - Featured , In the News / Politics , Professional Advice / Opinions

By: Maria Sorbera, PharmD Candidate c/o 2013 at AMSCOP (LIU) – Author William S. Burroughs states in his novel, “The question is frequently asked: Why does a man become a drug addict?  The answer is that he usually does not intend to become an addict. You don’t wake up one morning and decide to be…

Fungal Meningitis Outbreak: A Sobering Tragedy...
November 1, 2012 - In the News / Politics

By: Mahdieh Danesh Yazdi, Associate Student Editor – For the past few weeks, we have heard about the terrible breakout of fungal meningitis from contaminated methylprednisolone acetate vials manufactured by the New England Compounding Center (NECC).  Approximately 14,000 patients received medication from the contaminated lots.  So far, over 400 cases have been reported and over…

Are You Prepared for RSV Season?...
November 1, 2012 - Clinical , In the News / Politics

By: Mahdieh Danesh Yazdi, Associate Student Editor – Many of us have prepared for influenza season by receiving the flu vaccine.  (If you have not, please speak to your doctor or pharmacist soon!  Remember: even if you do not need it for your protection, get it for your patients’ well-being).  However, for the youngest members…

NYS Legislature to Ban Selling Tobacco Products in Phar...
October 1, 2012 - Featured , In the News / Politics , Professional Advice / Opinions

By: Mahdieh Danesh Yazdi – The views expressed in this article are solely those of the author and do not reflect the views of the Rho Chi Post, Rho Chi Beta Delta Chapter, or St. John’s University College of Pharmacy and Health Sciences.   For the past few months, I have been on rotation at…

College Of Pharmacy And Health Sciences – Name Ch...
September 1, 2012 - Events , Featured , In the News / Politics

 The College of Pharmacy and Allied Health Professions has officially changed its name to the College of Pharmacy and Health Sciences.  This is the college’s second name change since it was established in 1929. In order to truly encompass the current and future educational goals of the College of Pharmacy and Allied Health Professions, the…

Meet the new Beta 3 Agonist: Mirabegron (Myrbetriq®)...
August 1, 2012 - Clinical , Featured , In the News / Politics

By: Steve P. Soman – Mirabegron (Mybetriq®), known also by the brand name Betanis®in Japan, is a new once daily oral drug.   First in its class, it is a selective β(3)-adrenoceptor agonist that improves symptoms associated with over active bladder (OAB) such as urinary incontinence, urgency, and urinary frequency by enhancing storage function and relaxing…

Dr. Oz and Raspberry Ketones...
June 1, 2012 - Clinical , In the News / Politics , Professional Advice / Opinions

By: Lila Ahmed, Pharm.D. Candidate c/o 2013 – Whether you wish to admit it or not, all of us have watched or at least heard of the Dr. Oz Show.  I am sure that many of us encounter patients in the pharmacy who say, “I saw this on Dr. Oz; where could I find it?”…

Naloxone Distribution Programs...
June 1, 2012 - Clinical , Featured , In the News / Politics

By: Mahdieh Danesh Yazdi, Associate Student Editor, with Special Thanks to Dr. Tomasz Jodlowski for his contributions to this article – In the 1990s, major urban and rural areas across the United States grappled with a common problem: drug addiction.  At that time, the drugs of choice were illicit substances (i.e. heroin).  In order to combat…

New York Prescription Saver Card...
May 1, 2012 - In the News / Politics

By: Ebey P. Soman – https://nyprescriptionsaver.fhsc.com/asp/partners.asp New York Prescription Saver is a pharmacy discount program sponsored by New York State designed to help eligible New York State residents with no insurance to pay for their medications. To be eligible, you must be a resident of New York State; do not have Medicaid; either age 50…

Update: FTC Approves Medco and Express Scripts Merger...
May 1, 2012 - Featured , In the News / Politics

By: Mahdieh Danesh Yazdi, with Special Thanks to: Dr. Tomasz Jodlowski – In previous issues, we discussed an upcoming $29.1 billion merger between Express Scripts Inc. and Medco Health Solutions. The merger had been previously delayed by the Federal Trade Commission (FTC). The FTC wanted to verify that this upcoming merger would not violate any antitrust…

Sativex®: A Realistic Option for Advanced Cancer Pain?...
April 1, 2012 - Clinical , Featured , In the News / Politics

By: Kathlynn Ferrer, Pharm.D. Candidate c/o 2013 – Nabiximols (Sativex®) is a buccal spray that has been approved for use in the UK, Spain, Germany, Denmark, New Zealand, and Canada. The active ingredients in this product are Tetrahydrocannabinol and Cannabidiol, two kinds of cannabinoids1. Cannabinoids are chemical compounds that stimulate cannabinoid receptors and are the…

Korlym® For Endogenous Cushing’s Syndrome...
April 1, 2012 - Clinical , In the News / Politics

By: Alexandra Alleva, Pharm.D. Candidate c/o 2013 – On February 17, 2012, the US Food and Drug Administration (FDA) approved the first medication indicated specifically for patients with endogenous Cushing’s syndrome, a hormone disorder characterized by elevated blood levels of cortisol.  Mifepristone (Korlym®) is for the treatment of glucose intolerance and Type 2 Diabetes Mellitus…

Interview with: Mr. Phil Hecken, Director of Communicat...
April 1, 2012 - Featured , In the News / Politics , Professional Advice / Opinions

By: Mahdieh Danesh Yazdi – In previous issues, we discussed prescription drug abuse and several bills currently on the floor of the NYS Legislature, sponsored by Sen. Hannon which addressed the issue. On February 7th, I sat down with Sen. Hannon’s director of communications, Mr. Phil Hecken, and his legislative aide, Mr. Timothy Broschardt to…

The 2012 Update of the Beers Criteria for Potentially I...
April 1, 2012 - Clinical , In the News / Politics

By: Shannon Tellier – Medication related problems can be reduced in older adults if the Beers Criteria were utilized by health care professionals. The criteria serves as a guideline to identify potentially inappropriate medications (PIMs) that should be avoided in the elderly population, but it should not replace clinical judgment. This 2012 update includes a…

Counterfeit Prescription Medications: A Global Threat...
April 1, 2012 - Featured , In the News / Politics

By: Lunbao (Jerry) Huang, Pharm.D. Candidate c/o 2013 – Counterfeit prescription medications are becoming a great concern for us. They have increased worldwide costs and endangered our public safety. Activities related to counterfeit drugs cost our healthcare system an estimated $75 billion in 2010. Many patients were seriously injured and died due to counterfeit medications.…

Immunizations and Pharmacy...
April 1, 2012 - In the News / Politics

By: Mahdieh Danesh Yazdi – Many pharmacists were disappointed that New York was the 49th state to allow pharmacists to immunize in December 2008. Even then, the state legislature limited pharmacists to administering the influenza vaccine and the pneumococcal vaccine to those 18 years and older. There is now some exciting news from Albany. The…

Improving Patient and Health System Outcomes through Ad...
April 1, 2012 - In the News / Politics , Professional Advice / Opinions

By: Shannon Tellier – In December 2011, a report written to the United States (U.S.) Surgeon General, Dr. Regina Benjamin, discussed the importance of pharmacists in the healthcare system.  The objective of the report was to obtain support for expanding the roles of pharmacists in patient care, primary care, and public health services.  This evidence-based…

Drug Shortage Update: FDA Successfully Alleviates Chemo...
March 1, 2012 - In the News / Politics

By: Mahdieh Danesh Yazdi – As previously reported, there is currently great concern in the medical community because of the growing number of drug shortages.  Many of these are drugs that are critical to patient care, such as chemotherapy agents and antibiotics.  Last October, President Obama issued an executive order in an attempt to curb…

Jentadueto Approved by FDA for Type 2 Diabetes Mellitus...
March 1, 2012 - Clinical , In the News / Politics

By: Ebey P. Soman – The FDA recently approved a combination tablet of linagliptin with metformin hydrochloride (Jentadueto®) for the treatment of type 2 diabetes.  Developed by Boehringer Ingelheim and Eli Lilly, the new combination tablet provides a twice-daily treatment option for healthcare providers looking for greater flexibility in treating diabetes. Prescribers may add a…

FDA Makes Label Changes to Statins...
March 1, 2012 - Clinical , In the News / Politics

By: Mohamed Dungersi – On February 28, the U.S. Food and Drug Administration (FDA) approved important safety label changes for the class of cholesterol-lowering drugs known as statins.  Aligned with the FDA’s goal to provide the public with more information for the safe and effective use of statins, the agency made several modifications to the…

Inhaled Caffeine Under Investigation...
March 1, 2012 - Featured , In the News / Politics

By: Mahdieh Danesh Yazdi – A few months ago, a new product called AeroShot Pure Energy hit the markets in New York and Massachusetts.  AeroShot is a new inhaler that gives the user bursts of caffeine.  Each inhaler contains an estimated 100mg of caffeine, approximately the same amount as a large cup of coffee.  It…

I-STOP: The New Front Against Prescription Drug Abuse...
March 1, 2012 - In the News / Politics

By: Mahdieh Danesh Yazdi – As previously reported, the recent rise in violence against pharmacies (by people in search of narcotic medications) has riled the New York State legislature into action.  The attorney general has also joined the fray in the fight against prescription drug abuse.  Last June, Attorney General Eric T. Schneiderman, proposed setting…

Pharmacists in Alberta Allowed to Renew Prescriptions...
March 1, 2012 - In the News / Politics

By: Mohamed Dungersi – Starting July 1, 2012, Albertans will be able to have their prescriptions renewed at their local pharmacies and pharmacists will receive reimbursements for the service.  Patients will be able to renew medications for blood pressure, birth control, and asthma (particularly, inhalers) without waiting weeks to get into their family doctor’s office.…

Express Scripts and Medco Merger...
February 1, 2012 - In the News / Politics

By: Mahdieh Danesh Yazdi – Express Scripts Inc., one of the nation’s top pharmacy benefit managers (PBMs), has announced a $29 billion deal to take over one of its top competitors, Medco Health Solutions Inc.  Medco shareholders re-approved the merger on December 21.  For finalization, it needs the approval of Express Scripts’ shareholders and the…

Link Revealed: PPI Usage, Smoking and Bone Fractures...
February 1, 2012 - Clinical , In the News / Politics

By: Ebey P. Soman – Proton pump inhibitors (PPIs) are medications commonly prescribed to treat heartburn, acid reflux disease, and ulcers.  Almost a vast majority of patients in the United States seem to be taking a PPI, either as a prescription or from over-the-counter (OTC).  Researchers recently discovered associations between the long-term use of PPIs…

EPIC Spells Trouble for Many Seniors...
February 1, 2012 - In the News / Politics

By: Ebey P. Soman – New York State’s Elderly Pharmaceutical Insurance Coverage Program (EPIC) is a secondary prescription insurance program for over 280,000 income-eligible seniors aged 65 and older.  The program supplements members’ out-of-pocket Medicare Part D drug plan costs.  To be eligible, the senior must be a state resident with an annual income of…

The Latest Novartis Recalls...
February 1, 2012 - In the News / Politics

By: Aleena Chacko, Long Island University Pharm.D. Candidate c/o 2013 – Established in 1996, Novartis International AG is a multinational pharmaceutical company based in Switzerland.  On January 8, 2012, Novartis issued a recall on some popular over the counter (OTC) medications in the United States (U.S.) over concerns about broken or incorrect tablets ending up…

Medco & Express Scripts Merger...
February 1, 2012 - In the News / Politics

By: Alisha Kumar, PharmD Candidate c/o 2012 – Express Scripts proposed a $29 billion acquisition of Medco Health back in July 2011, and Medco’s shareholders almost unanimously accepted the offer.  According to Medco’s press release, the plan was approved by a margin of 99% to 1%, with approximately 72% of its shareholders voting. The two…

Bydureon®: A Weekly Injection for Type 2 Diabetes Mell...
February 1, 2012 - Clinical , Featured , In the News / Politics

By: Mohamed Dungersi – On January 27, the FDA approved Bydureon® (exenatide extended-release) for use in Type 2 Diabetes Mellitus (T2DM), as an adjunct to diet and exercise.  Bydureon®, a product of Amylin Pharmaceuticals, is a modified formulation of the twice-daily injection, Byetta® (exenatide).  It is the first once-a-week medication for T2DM in the market.…

Hope on the Horizon: Chikungunya Vaccine Trial Begins!...
January 1, 2012 - Clinical , Featured , In the News / Politics

By: Ebey P. Soman – Since its discovery in Tanganyika (modern day Mozambique and Tanzania in Africa) in 1952, Chikungunya virus outbreaks have been documented in Africa, South Asia, and Southeast Asia.  Due to recent globalization and increased travel, infection has also spread outside of tropical regions and even into western nations (such as the…

New Oral Direct Thrombin Inhibitors and Factor Xa Antic...
January 1, 2012 - Clinical , Featured , In the News / Politics

By: Neal Shah – Anticlotting agents are staples in the prevention and treatment of thrombotic disorders, such as deep vein thrombosis, stroke, pulmonary embolism, myocardial infarction, and atrial fibrillation.1  Intravenous medications, such as unfractionated heparin (UFH), low molecular weight heparin (LMWH), and direct thrombin inhibitors (DTI), are commonly used in, both, inpatient and outpatient settings.…

FDA Challenges Pharmacists’ Right to Compound...
January 1, 2012 - Featured , In the News / Politics

By: Ebey P. Soman – With clearly established roles for pharmacists, compounding is recognized and upheld as a core foundation of the pharmacy profession.   It allows pharmacists to provide unique and tailored medication regimens for their patients.  The U.S. Food and Drug Administration (FDA) thought otherwise when the agency sued Franck’s Lab, Inc., a Florida-based…

FDA Approves Edarbyclor®...
January 1, 2012 - Clinical , In the News / Politics

By: Gokul Kalla, Pharm.D. Candidate c/o 2013 – Hypertension is a chronic disease that affects one out of every three Americans.  Leaving the condition untreated could increase the risk of serious health consequences such as a stroke or a heart attack.  On December 21, the FDA approved Takeda Pharmaceuticals’ Edarbyclor® (azilsartan medoxomil and chlorthalidone) for…

Placement of Carisoprodol into Schedule IV...
January 1, 2012 - In the News / Politics

By Jena Marion, Pharm.D. Candidate c/o 2013 – On December 12, 2011, the Administrator of the Drug Enforcement Agency (DEA) ruled to place carisoprodol (Soma®) into Schedule IV of the Controlled Substances Act (CSA).  Carisoprodol has been in use since it was approved for marketing in the U.S. in 1959 with the indication of “relief…

New York Lawmakers Tackle Prescription Drug Abuse...
January 1, 2012 - In the News / Politics

By: Mahdieh Danesh Yazdi – We have all heard the mortifying tales of recent attacks on pharmacies by addicts looking to steal prescription pain-killers. Most notable perhaps, was the case of David Laffers. Mr. Laffers walked into Haven Drugs in Medford, NY and killed the pharmacist, a store clerk, and two customers, who happened to…

Post navigation

← Older posts
Newer posts →


Do You Want to be a Published Author? Submit your Article(s) Today!



Tweets by @RhoChiPost

HOME: Home Page

VOLUMES / ISSUES: 14 . 13 . 12 . 11 . 10 . 9 . 8 . 7 . 6 . 5 . 4 . 3 . 2 . 1

ARTICLES: Featured . In the News / Politics . Events . Clinical . Advice / Opinions . Puzzles

FOR AUTHORS: Guidelines . AMA Citation Generator . Sign Up . Suggest . Submit . Cite

ABOUT US: About the Rho Chi Post . The Editorial Team . Apply for a Position

SUBSCRIBE: Google Groups Email List


Copyright © 2011-2025 Rho Chi Post